CanSinoBIO at WGS 2026: Accelerating Global Access to Innovative Vaccines

DUBAI, Feb. 9, 2026 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO"; SSE: 688185, HKEX: 06185) has been invited to share the practices of innovative vaccine at the World Government Summit 2026 (WGS 2026) which convened from February 3 to 5 in Dubai, UAE under the theme of "Shaping Future Governments." CanSinoBIO stands the sole global vaccine maker invited to the World Government Summit for the second consecutive year. Continue Reading In 2022, it launched the world's first inhaled COVID-19 vaccine, wh ...